Gemcitabine in models of acute and accelerated rejection.
Jung
F
F
Department of General and Thoracic Surgery, Justus Liebig University, Giessen, Germany.
Wilker
S
S
Maas
E
E
Brendel
M D
MD
Grimm
H
H
Korom
S
S
D000208:Acute Disease; D000818:Animals; D003602:Cytotoxicity, Immunologic; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013997:Time Factors; D014184:Transplantation, Homologous; D000093542:Gemcitabine
D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D000093542:Gemcitabine